GE HealthCare Technologies Inc. $GEHC Position Raised by Nordea Investment Management AB

Nordea Investment Management AB lifted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 564.4% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 284,344 shares of the company’s stock after acquiring an additional 241,548 shares during the period. Nordea Investment Management AB owned 0.06% of GE HealthCare Technologies worth $23,515,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Wedge Capital Management L L P NC acquired a new position in shares of GE HealthCare Technologies during the third quarter worth approximately $26,859,000. Valicenti Advisory Services Inc. increased its position in GE HealthCare Technologies by 22.6% in the 3rd quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company’s stock valued at $5,115,000 after acquiring an additional 12,550 shares during the period. Temasek Holdings Private Ltd bought a new stake in GE HealthCare Technologies during the 3rd quarter valued at $99,922,000. Locust Wood Capital Advisers LLC raised its stake in GE HealthCare Technologies by 7.1% during the 3rd quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company’s stock valued at $156,534,000 after acquiring an additional 137,992 shares in the last quarter. Finally, Nan Fung Trinity HK Ltd. acquired a new position in GE HealthCare Technologies during the 3rd quarter worth $23,206,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on GEHC. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 29th. Citigroup reduced their price objective on shares of GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating for the company in a report on Wednesday, March 11th. Bank of America increased their target price on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research report on Monday, January 5th. Piper Sandler raised their target price on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the company an “overweight” rating in a research note on Friday, January 30th. Finally, Jefferies Financial Group boosted their price target on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. Seven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, GE HealthCare Technologies presently has an average rating of “Hold” and a consensus target price of $92.17.

Check Out Our Latest Stock Analysis on GEHC

GE HealthCare Technologies Stock Down 1.0%

Shares of GEHC stock opened at $70.96 on Wednesday. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $89.77. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. The business’s fifty day moving average is $78.64 and its 200-day moving average is $78.42. The stock has a market cap of $32.38 billion, a PE ratio of 15.56, a price-to-earnings-growth ratio of 1.57 and a beta of 1.03.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. During the same quarter in the prior year, the firm posted $1.45 earnings per share. The company’s revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio is presently 3.07%.

About GE HealthCare Technologies

(Free Report)

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

Read More

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.